-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Xylem, Raises Price Target to $133

Benzinga·04/29/2026 18:53:53
Listen to the news
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $132 to $133.